Support for strong IP protections for biologics and pharmaceuticals, consistent with US law, to be included in the Trans-Pacific Partnership (TPP) trade agreement. Support domestic and international corporate tax policies which protect and incentivize US-based research and manufacturing jobs. 1) Opposition to proposals to weaken incentives included in the biosimilars law for innovation and second generation therapies.
2) Support for appropriate guidance, comment period, and implementation timelines as required by PL 111-148 Section 6002.
3) Oppose efforts to expand importation of prescription drugs without adequate safety standards and patient protections. Opposition to changes to Medicare Parts D and B reimbursement systems which could have adverse impact on patient access and US-based jobs.
TRD - Trade (domestic/foreign) TAX - Taxation/Internal Revenue Code HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR)
BIOGEN
601 PENNSYLVANIA AVENUE, NW #720, WASHINGTON, DC, 20004, US
KATHLEEN TREGONING (Staff, House Ways and Means Committee) ADAM GLUCK (Staff, Senate HELP Committee) KATHLEEN TREGONING (Staff, House Ways and Means Committee) ADAM GLUCK (Staff, Senate HELP Committee) KATHLEEN TREGONING (Staff, House Ways and Means Committee) ADAM GLUCK (Staff, Senate HELP Committe) KATHLEEN TREGONING (Staff, House Ways and Means Committee) ADAM GLUCK (Staff, Senate HELP Committee)
Staff, House Ways and Means Committee Staff, Senate HELP Committee Staff, House Ways and Means Committee Staff, Senate HELP Committee Staff, House Ways and Means Committee Staff, Senate HELP Committe Staff, House Ways and Means Committee Staff, Senate HELP Committee